These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8844612)
21. Effect of Piper betle on cardiac function, marker enzymes, and oxidative stress in isoproterenol-induced cardiotoxicity in rats. Arya DS; Arora S; Malik S; Nepal S; Kumari S; Ojha S Toxicol Mech Methods; 2010 Nov; 20(9):564-71. PubMed ID: 20846025 [TBL] [Abstract][Full Text] [Related]
22. The acute lethal dose 50 (LD50) of caffeine in albino rats. Adamson RH Regul Toxicol Pharmacol; 2016 Oct; 80():274-6. PubMed ID: 27461039 [TBL] [Abstract][Full Text] [Related]
23. Acute adriamycin cardiotoxicity in rats. Porta EA; Joun NS; Matsumura L; Nakasone B; Sablan H Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):125-37. PubMed ID: 6622826 [TBL] [Abstract][Full Text] [Related]
24. [Isoproterenol toxicity in the myocardium in an experiment]. Ljubuncić P; Mujić F; Winterhalter M; Huković N; Vidović Z; Duricić S Arh Hig Rada Toksikol; 1992 Mar; 43(1):11-20. PubMed ID: 1510612 [TBL] [Abstract][Full Text] [Related]
25. Licorice treatment prevents oxidative stress, restores cardiac function, and salvages myocardium in rat model of myocardial injury. Ojha SK; Sharma C; Golechha MJ; Bhatia J; Kumari S; Arya DS Toxicol Ind Health; 2015 Feb; 31(2):140-52. PubMed ID: 23771872 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats. Tonomura Y; Mori Y; Torii M; Uehara T Toxicology; 2009 Dec; 266(1-3):48-54. PubMed ID: 19854236 [TBL] [Abstract][Full Text] [Related]
27. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Prince PS; Sathya B Eur J Pharmacol; 2010 Jun; 635(1-3):142-8. PubMed ID: 20206157 [TBL] [Abstract][Full Text] [Related]
28. Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice. Bjelogrlic SK; Radic J; Jovic V; Radulovic S Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):311-9. PubMed ID: 16236144 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. Johansson S Acta Pathol Microbiol Scand A; 1981 May; 89(3):185-91. PubMed ID: 6118996 [TBL] [Abstract][Full Text] [Related]
30. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin. Kratz F; Ehling G; Kauffmann HM; Unger C Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177 [TBL] [Abstract][Full Text] [Related]
31. [Acute and postponed action of adriamycin on the contractile function and antioxidant status of the myocardium]. Kapel'ko VI; Lakomkin VL; Konovalova GG; Tsyplenkova VG; Tikhaze AK; Lankin VZ Kardiologiia; 2010; 50(12):45-51. PubMed ID: 21591392 [TBL] [Abstract][Full Text] [Related]
32. Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection. Zeidán Q; Strauss M; Porras N; Anselmi G J Submicrosc Cytol Pathol; 2002 Jul; 34(3):315-21. PubMed ID: 12408365 [TBL] [Abstract][Full Text] [Related]
33. Integration of cardiac energetics, function and histology from isolated rat hearts perfused with doxorubicin and doxorubicin-ol; a model for use in drug safety evaluations. Henderson KA; Borders RB; Ross JB; Abdulalil A; Gibbs S; Skowronek AJ; Knostman K; Bailey J; Smith J; Vinci T; Wood B; Knopp MV; Roche BM J Pharmacol Toxicol Methods; 2018; 94(Pt 2):54-63. PubMed ID: 30195582 [TBL] [Abstract][Full Text] [Related]
34. Cardiotoxic effects of high doses of cyclophosphamide in albino rats. Kumar S; Gupta RK; Bhake AS; Samal N Arch Int Pharmacodyn Ther; 1992; 319():58-65. PubMed ID: 1285674 [TBL] [Abstract][Full Text] [Related]
35. IMPACT OF ISOPRENALINE AND CAFFEINE ON DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY AND RENAL HEMODYNAMIC IN WISTAR KYOTO RATS. Ahmad A; Sattar MZ; Rathore HA; Khan SA; Lazhari MA; Hashmi F; Abdullah NA; Johns EJ Acta Pol Pharm; 2015; 72(5):1015-26. PubMed ID: 26665409 [TBL] [Abstract][Full Text] [Related]
36. Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function. Jones SM; Kirby MS; Harding SE; Vescova G; Wanless RB; Dalla Libera LD; Poole-Wilson PA Cardiovasc Res; 1990 Oct; 24(10):834-42. PubMed ID: 2150789 [TBL] [Abstract][Full Text] [Related]
37. Ultrastructure of isoproterenol-induced myocardial damage in chick embryos. Dusek J; Ostádal B Physiol Bohemoslov; 1985; 34(4):297-302. PubMed ID: 2932749 [TBL] [Abstract][Full Text] [Related]
38. Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats. Nishimura Y; Kondo C; Morikawa Y; Tonomura Y; Torii M; Yamate J; Uehara T J Appl Toxicol; 2015 Feb; 35(2):173-80. PubMed ID: 25092230 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin. Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186 [TBL] [Abstract][Full Text] [Related]
40. Isoproterenol induced myocardial lesions in the immunized and non-immunized rat. II. Histopathological lesions after specific immunization. Gazenfeld E; Rosenmann E; Davies AM; Laufer A Immunology; 1966 Feb; 10(2):193-8. PubMed ID: 5932901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]